Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Slippery Slope

Logically wouldn't a CEO of a company that has been bombarded by e-mails from shareholders that have voiced concerns over their investment be able to communicate something to the shareholders to assuage the fears without violating an embargo.

PDSG? Expectations ? How about an update as to how the product is being recieved, implemented and or the timeline moving forward if it is not a profitable investment.

So your take is this silence is very obvious and logically induced by the litigation with TPL?

Thanks for the response,

TW

Share
New Message
Please login to post a reply